When Tom Fulmer and I sat down recently to present our webinar to occupational health providers, I couldn’t help but notice how much the room—whether virtual or in person—has changed over the years. The questions coming in weren’t the simple, straightforward ones we used to see. Instead, providers were wrestling with challenges: new laws, new drugs, new expectations, and the pressure of becoming something more than a place where specimens get collected.
Here is the webinar recording for our topic: The Evolving Drug Testing Landscape: What Occupational Health Providers Must Know in 2026
What we shared in that webinar, and what I want to share here—is that the drug testing industry is in the middle of one of its biggest shifts in decades. The landscape is being reshaped by forces that touch every corner of an employer’s drug and alcohol testing program. Clinics today aren’t just collection sites; they’re strategic partners employers rely on for guidance, clarity, and compliance.
And that evolution is happening fast.
A Landscape Moving Faster Than Employers Can Follow
As we spoke with providers, it became clear that many employers feel like the ground is moving beneath them. Regulations are changing quickly, workplace attitudes are evolving, and the expectations for clinics have grown far beyond “just do the test.”
A few themes kept coming up again and again:
- Marijuana legalization continues to accelerate, leaving employers confused about policy, impairment, and safety.
- New drugs—especially fentanyl and emerging synthetics—are raising serious safety concerns.
- Employers want faster turnaround times and digital workflows.
- For-cause and post-accident tests are showing shockingly high positivity rates.
- Remote and mobile collections are no longer niche; they’re becoming standard expectations.
Positivity Trends Telling a New Story
THC positivity sits around 4.5%, amphetamines around 1.7%, and overall urine positivity hovers near 4.4%. But where eyes really opened was with for-cause testing—hovering at 33.1% positivity—and the rising number of fentanyl detections, even in random testing.
The Marijuana Question Employers Can’t Escape
No topic generates more questions than marijuana. And no wonder—state laws shift constantly, employees misunderstand what “legal” means in the workplace, and CBD products muddy the waters even further.
Clinics can offer tremendous value by supporting:
- Guidance on state laws regarding marijuana drug testing
- Policy reviews
- Supervisor training
- Behavior-based documentation
- Guidance on specimen type selection
- Drug-laced vapes
New Drugs, New Risks, New Panels
Emerging substances are changing how employers think about safety, compliance, and detection. More employers are turning to expanded 10-, 13-, and 17-panel options, EtG monitoring, and deeper MRO consultation to address fentanyl and polysubstance use. Other emerging substances to be considered include:
- Synthetic Cannabinoids (K2/Spice) and bath salts
- CBD products many contain THC levels that can cause marijuana positive results
- Kratom
- Psilocybin mushrooms
The biggest challenge isn’t just new drugs — it’s the speed at which they evolve.
Employers are adapting by:
- Updating panel selections more frequently
- Adding synthetic drug testing
- Implementing random or post-accident oral fluid programs
- Strengthening reasonable-suspicion training
Technology Is Transforming Testing
Oral fluid testing has become a significant change—observed, and tamper-resistant. Technology such as eCCFs, AI-enhanced MRO tools, and digital platforms are driving accuracy and efficiency. Instant drug testing with both urine and oral fluid offers opportunities for digital collection and immediate negative results.
DOT Updates to Watch
- Oral fluid rollout
- Revised collector training
- SAP guideline updates
- Potential future inclusion of fentanyl
- Greater emphasis on eCCF’s
Opportunities for Clinics Ready to Lead
Clinics can stand out by offering:
- Supervisor reasonable suspicion training
- Policy consulting
- Employer education
- Post-accident assistance
- Mobile/concierge services
- MRO support
Operational Excellence Matters
- Strong chain-of-custody procedures
- Thorough documentation
- Regular collector training
- Improved turnaround times
A Case That Says It All
A manufacturer in a legalized marijuana state struggled with compliance and hiring. After partnering with a knowledgeable clinic that provided policy review, oral fluid implementation, and supervisor training, their refusals and positives dropped and compliance improved. This lead to a safer workplace.
Forward Opportunities for Occupational Health Providers
- Stay current with changing laws.
- Update testing panels and technology.
- Train collectors consistently.
- Build employer education resources.
- Improve reporting and turnaround.
- Market your expertise confidently.
Clinics that embrace a leadership role will deepen relationships, improve outcomes, and grow sustainably.
Frequently Asked Questions
Why is the drug testing landscape changing so quickly?
The industry is being reshaped by marijuana legalization, the rise of fentanyl and synthetic substances, and rapid technological advancements. Employers are overwhelmed and increasingly rely on clinics for clarity and guidance.
How is marijuana legalization affecting workplace drug testing?
State-by-state rules vary significantly, leading to confusion. Employers struggle to interpret impairment, CBD complications, and safety-sensitive exceptions. Clinics help bridge the gap with policies, training, and documentation.
What positivity trends are emerging?
THC positivity is rising, fentanyl is appearing even in random tests, and for-cause positivity rates exceed 33%. These trends highlight the need for updated test panels and stronger employer education.
Why are employers expanding their testing panels?
Traditional panels may not detect fentanyl or newer synthetics. Employers now prefer 10-, 13-, or 17-panel options to ensure workplace safety.
How is oral fluid testing changing the testing landscape?
Oral fluid testing is DOT-approved, observed, tamper-resistant, and fast. It provides a modern, efficient alternative to urine and is becoming increasingly popular with employers.
What technologies are improving drug testing programs?
eCCFs, AI-assisted MRO tools, and digital occupational platforms are reducing errors and speeding up processes, helping clinics deliver better service.
What challenges exist with impairment vs. intoxication?
A positive THC test does not prove impairment. Clinics help employers document behavior, train supervisors, and align policy language with legal requirements.
How can clinics grow their drug testing business?
By offering supervisor training, policy consulting, mobile collections, employer education, post-accident support, and MRO-related services.
Why are clinics becoming advisors rather than just collection sites?
Employers face complex legal and operational challenges and need expert partners who can interpret laws, recommend testing strategies, and provide training.
How can clinics stay ahead of ongoing changes?
Stay updated on laws, invest in modern testing technologies, regularly train staff, develop educational tools for employers, and market advisory expertise confidently.
